Assessing clinical response in multiple myeloma (MM) patients treated with monoclonal antibodies (mAbs): Validation of a daratumumab IFE reflex assay (DIRA) to distinguish malignant M-protein from therapeutic antibody.-Reference-Cited by-同舟云学术

Assessing clinical response in multiple myeloma (MM) patients treated with monoclonal antibodies (mAbs): Validation of a daratumumab IFE reflex assay (DIRA) to distinguish malignant M-protein from therapeutic antibody.

Published:2015-05-20 Issue:15_suppl Volume:33 Page:8590-8590
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

McCudden Christopher¹,Axel Amy²,Slaets Dominique³,Frans Sandy⁴,Bald Jaime²,Schecter Jordan Mark⁵,Ahmadi Tahamtan²,Plesner Torben⁶,Sasser Kate²

Affiliation:

1. Dept. of Pathology & Lab. Medicine, The Ottawa Hospital University of Ottawa, Ottawa, ON, Canada

2. Janssen Research and Development, Spring House, PA

3. BARC, a division of CERBA European Lab, Ghent, Belgium

4. Janssen Research and Development, Beerse, Belgium

5. Janssen Research and Development, Raritan, NJ

6. Vejle Hospital and University of Southern Denmark, Vejle, Denmark

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2015.33.15_suppl.8590

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of M‐protein detection on the response evaluations of patients undergoing treatment with the IgG‐κ monoclonal antibodies daratumumab or isatuximab, and discrepancies between immunofixation electrophoresis (IFE) systems and reagents;Cancer Medicine;2024-08

2. Review of daratumumab efficacy in all monoclonal gammopathies and other diseases and our experience with daratumumab, lenalidomide and dexamethasone therapy in 74 patients;Onkologie;2022-10-14

3. Daratumumab: A review of current indications and future directions;Seminars in Oncology;2022-02

4. Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates;Hemato;2021-03-01

5. Immune Signatures Associated With Clonal Isotype Switch After Autologous Stem Cell Transplantation for Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2019-05